20 Healthcare Stocks Moving In Thursday's Pre-Market Session

Gainers

• Tetraphase Pharmaceutical, Inc. TTPH shares rose 49.82% to $2.03 during Thursday's pre-market session. According to the most recent rating by Gabelli & Co., on Mar 17, the current rating is at Sell.

• Biomerica, Inc. BMRA stock increased by 30.53% to $8.55.

• Tonix Pharmaceuticals, Inc. TNXP shares rose 24.34% to $0.87.

• Evelo Biosciences, Inc. EVLO shares rose 20.04% to $5.75.

• Titan Pharmaceuticals, Inc. TTNP shares moved upwards by 18.47% to $0.34.

• Sesen Bio, Inc. SESN shares increased by 17.57% to $0.74.

• AEterna Zentaris, Inc. AEZS shares moved upwards by 13.86% to $1.15.

• Livongo Health, Inc. LVGO stock moved upwards by 12.76% to $52.95. The most recent rating by Needham, on May 7, is at Buy, with a price target of $55.

• Conatus Pharmaceuticals, Inc. CNAT stock moved upwards by 11.63% to $0.48.

• Natera, Inc. NTRA stock increased by 11.58% to $40. The most recent rating by JP Morgan, on May 7, is at Overweight, with a price target of $45.

Losers

• Predictive Oncology, Inc. POAI shares declined 13.33% to $1.30 during Thursday's pre-market session.

• Macrogenics, Inc. MGNX stock fell 9.18% to $22.84. The most recent rating by Credit Suisse, on May 6, is at Outperform, with a price target of $13.

• ADMA Biologics, Inc. ADMA shares fell 8.44% to $2.93. The most recent rating by H.C. Wainwright, on Mar 16, is at Buy, with a price target of $12.

• Agile Therapeutics, Inc. AGRX stock decreased by 6.50% to $2.30. The most recent rating by H.C. Wainwright, on Mar 20, is at Buy, with a price target of $6.

• Bionano Genomics, Inc. BNGO shares fell 6.21% to $0.34. The most recent rating by Oppenheimer, on Apr 8, is at Outperform, with a price target of $2.

• Zafgen, Inc. ZFGN stock fell 4.71% to $0.85.

• Cellectis, Inc. CLLS shares declined 4.64% to $13.78. The most recent rating by Goldman Sachs, on Mar 6, is at Sell, with a price target of $11.

• Ritter Pharmaceuticals, Inc. RTTR shares fell 4.50% to $0.42.

• Axcella Health, Inc. AXLA shares decreased by 4.42% to $5.40. The most recent rating by BTIG, on May 1, is at Buy, with a price target of $10.

• KemPharm, Inc. KMPH shares fell 4.35% to $0.25.